Welcome to LookChem.com Sign In|Join Free

CAS

  • or

402933-56-6

Post Buying Request

402933-56-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

402933-56-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 402933-56-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,2,9,3 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 402933-56:
(8*4)+(7*0)+(6*2)+(5*9)+(4*3)+(3*3)+(2*5)+(1*6)=126
126 % 10 = 6
So 402933-56-6 is a valid CAS Registry Number.

402933-56-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methyl-2-propanyl [6-(2-hydroxyethyl)-2-pyridinyl]carbamate

1.2 Other means of identification

Product number -
Other names t-butyl-5-oxo hexanoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:402933-56-6 SDS

402933-56-6Relevant articles and documents

Synthesis and structure–activity relationship of 2,6-disubstituted pyridine derivatives as inhibitors of β-amyloid-42 aggregation

Kroth, Heiko,Sreenivasachary, Nampally,Hamel, Anne,Benderitter, Pascal,Varisco, Yvan,Giriens, Valérie,Paganetti, Paolo,Froestl, Wolfgang,Pfeifer, Andrea,Muhs, Andreas

supporting information, p. 3330 - 3335 (2016/07/12)

It is assumed that amyloid-β aggregation is a crucial event in the pathogenesis of Alzheimer's disease. Novel 2,6-disubstituted pyridine derivatives were designed to interact with the β-sheet conformation of Aβ via donor–acceptor–donor hydrogen bond forma

Gem-substituted αvβ3 antagonists

-

, (2008/06/13)

The present invention relates to a class of compounds represented by the Formula I. or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αVβ3and/or the αVβ5integrin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 402933-56-6